top of page

Sunlenca solution for injection 463.5mg/1.5ml

Product details

Registration number: SIN17189P

Classification: Prescription Only

Active ingredients: Lenacapavir Sodium eqv Lenacapavir

Strength: 463.5mg/1.5ml

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.

ATC code: J05AX31

HSA approval date: 27 February 2025

Manufacturer(s):

  • Patheon Italia, S.p.A.
  • Hikma Farmaceutica (Portugal) S.A.

Manufacturing country/countries: ITALY; PORTUGAL

What are the HSA registration number and classification for Sunlenca solution for injection 463.5mg/1.5ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17189P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Sunlenca solution for injection 463.5mg/1.5ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Lenacapavir Sodium eqv Lenacapavir

Strength: 463.5mg/1.5ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Sunlenca solution for injection 463.5mg/1.5ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Source for this answer

Who is the recorded registrant for Sunlenca solution for injection 463.5mg/1.5ml?

According to the HSA dataset updated 7 August 2026:

Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Sunlenca solution for injection 463.5mg/1.5ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Patheon Italia, S.p.A.
  • Hikma Farmaceutica (Portugal) S.A.

Manufacturing country/countries: ITALY; PORTUGAL

Source for this answer

Where can I look up Sunlenca solution for injection 463.5mg/1.5ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17189P or the exact product name Sunlenca solution for injection 463.5mg/1.5ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Sunlenca solution for injection 463.5mg/1.5ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Sunlenca solution for injection 463.5mg/1.5ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17189P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page